These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 27338587)

  • 1. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
    Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
    Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Frémont M; Coomans D; Massart S; De Meirleir K
    Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
    Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
    Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery.
    Martín F; Blanco-Suárez M; Zambrano P; Cáceres O; Almirall M; Alegre-Martín J; Lobo B; González-Castro AM; Santos J; Domingo JC; Jurek J; Castro-Marrero J
    Front Immunol; 2023; 14():1253121. PubMed ID: 37744357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
    König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
    Front Immunol; 2021; 12():628741. PubMed ID: 35046929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.
    Guo C; Che X; Briese T; Ranjan A; Allicock O; Yates RA; Cheng A; March D; Hornig M; Komaroff AL; Levine S; Bateman L; Vernon SD; Klimas NG; Montoya JG; Peterson DL; Lipkin WI; Williams BL
    Cell Host Microbe; 2023 Feb; 31(2):288-304.e8. PubMed ID: 36758522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.
    Mandarano AH; Giloteaux L; Keller BA; Levine SM; Hanson MR
    PeerJ; 2018; 6():e4282. PubMed ID: 29375937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.
    Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG
    Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
    Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
    Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
    Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.
    Citronberg JS; Curtis KR; White E; Newcomb PA; Newton K; Atkinson C; Song X; Lampe JW; Hullar MA
    ISME J; 2018 Jun; 12(7):1631-1641. PubMed ID: 29434315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M; Leunis JC; Geffard M; Berk M
    Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
    Newberry F; Hsieh SY; Wileman T; Carding SR
    Clin Sci (Lond); 2018 Mar; 132(5):523-542. PubMed ID: 29523751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation.
    Kiecolt-Glaser JK; Wilson SJ; Bailey ML; Andridge R; Peng J; Jaremka LM; Fagundes CP; Malarkey WB; Laskowski B; Belury MA
    Psychoneuroendocrinology; 2018 Dec; 98():52-60. PubMed ID: 30098513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.
    Wallis A; Ball M; Butt H; Lewis DP; McKechnie S; Paull P; Jaa-Kwee A; Bruck D
    J Transl Med; 2018 Feb; 16(1):24. PubMed ID: 29409505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.
    Severance EG; Gressitt KL; Stallings CR; Origoni AE; Khushalani S; Leweke FM; Dickerson FB; Yolken RH
    Schizophr Res; 2013 Aug; 148(1-3):130-7. PubMed ID: 23746484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.